Altre lingue ABL Diagnostics

Azioni

ABLD

FR001400AHX6

Mercato chiuso - Euronext Paris Altri mercati azionari 11:30:21 03/05/2024			Variaz. 5gg	Var. 1 gen.
3,14 ^EUR	+1,29%		+2,61%	-67,63%

2023	ABL Diagnostics Société anonyme riporta i risultati degli utili per il semestre conclusosi il 30 giugno 2023	CI
2023	ABL Diagnostics Société anonyme riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2022	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ABL DIAGNOSTICS : MISE EN PLACE D’UN CONTRAT DE LIQUIDITE AVEC ALLINVEST SECURITIES	23/04
AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S.	17/04
AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties' clinical trials in the USA	16/04
ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.	18/03
Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B)	04/03
Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA	28/02
ABL Diagnostics and AB ANALITICA join forces to offer microbiology genotyping solutions in Italy.	28/02
AdvancedDx Biological Laboratories USA Inc. announces its new temperature-controlled warehouse in the USA	20/02
ABL Diagnostics announces the release of its DeepChek®-HPV Assay, to be used for Human Papillomavirus screening, genotyping, and discrimination through sequencing.	18/01
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	21/12
ABL DIAGNOSTICS INTRODUCING CRISPRCHEK - A NEW LINE OF ASSAYS USING THE CRISPR TECHNOLOGY	18/12
ABL Diagnostics releases new applications for respiratory viruses including Influenza, RSV and SARS-CoV-2	06/12
ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING	30/11
ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.	24/11
ABL Diagnostics : Document AMF CP. 2023DD925593	01/09/23
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	01/08/23
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa	27/03/23
Roche Diagnostics (Pty) Ltd and ABL Diagnostics enter into an Exclusive Distribution Agreement in South Africa	27/03/23
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	02/09/22
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons.	31/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ABL Diagnostics

Azioni

ABLD

FR001400AHX6

Altre lingue

Filtri